| |
| | Prepared Witness Testimony: Levy, Michael (Site not responding. Last check: 2007-10-10) |
 | | Clinically, the predictable pharmacokinetics of OxyContin are demonstrated by the independence of its dissolution on pH and the high correlation of its dose with its plasma level (Kaiko et al 1996b, Benziger et al 1996, Kaiko 1997, Mucci-LoRusso et al 1998, Mandema et al 1998). |
 | | Kaiko RF, Benziger DP, Fitzmartin RD, Burke BE, Reder RF, Goldenheim PD. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone. |
 | | Kaiko RF, Benziger D, Cheng C, Hou Y, Grandy R. Analgesic onset and potency of oral controlled-release (CR) oxycodone and CR morphine. |
| energycommerce.house.gov /107/hearings/08282001Hearing363/Levy602print.htm (2830 words) |
|